Literature DB >> 32424634

Antagonizing the renin-angiotensin-aldosterone system in the era of COVID-19.

Riccardo Sarzani1,2,3, Federico Giulietti4,5, Chiara Di Pentima4,5, Andrea Filipponi4,5, Francesco Spannella4,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32424634      PMCID： PMC7233190          DOI： 10.1007/s11739-020-02365-5

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  8 in total

1.  Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China.

Authors:  Juyi Li; Xiufang Wang; Jian Chen; Hongmei Zhang; Aiping Deng
Journal:  JAMA Cardiol       Date:  2020-07-01       Impact factor: 14.676

2.  Renin-Angiotensin System Blockers and Statins Are Associated With Lower In-Hospital Mortality in Very Elderly Hypertensives.

Authors:  Francesco Spannella; Federico Giulietti; Paolo Balietti; Guido Cocci; Laura Landi; Francesca Elena Lombardi; Elisabetta Borioni; Beatrice Bernardi; Giulia Rosettani; Valentina Bordoni; Riccardo Sarzani
Journal:  J Am Med Dir Assoc       Date:  2017-11-08       Impact factor: 4.669

3.  Losartan prevents sepsis-induced acute lung injury and decreases activation of nuclear factor kappaB and mitogen-activated protein kinases.

Authors:  Lihan Shen; Hongying Mo; Lin Cai; Tianhan Kong; Weihao Zheng; Jihui Ye; Junhua Qi; Zhenglun Xiao
Journal:  Shock       Date:  2009-05       Impact factor: 3.454

4.  Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients.

Authors:  Sana Salehi; Aidin Abedi; Sudheer Balakrishnan; Ali Gholamrezanezhad
Journal:  AJR Am J Roentgenol       Date:  2020-03-14       Impact factor: 3.959

5.  Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19.

Authors:  Peng Zhang; Lihua Zhu; Jingjing Cai; Fang Lei; Juan-Juan Qin; Jing Xie; Ye-Mao Liu; Yan-Ci Zhao; Xuewei Huang; Lijin Lin; Meng Xia; Ming-Ming Chen; Xu Cheng; Xiao Zhang; Deliang Guo; Yuanyuan Peng; Yan-Xiao Ji; Jing Chen; Zhi-Gang She; Yibin Wang; Qingbo Xu; Renfu Tan; Haitao Wang; Jun Lin; Pengcheng Luo; Shouzhi Fu; Hongbin Cai; Ping Ye; Bing Xiao; Weiming Mao; Liming Liu; Youqin Yan; Mingyu Liu; Manhua Chen; Xiao-Jing Zhang; Xinghuan Wang; Rhian M Touyz; Jiahong Xia; Bing-Hong Zhang; Xiaodong Huang; Yufeng Yuan; Rohit Loomba; Peter P Liu; Hongliang Li
Journal:  Circ Res       Date:  2020-04-17       Impact factor: 17.367

6.  Angiotensin-converting enzyme 2 protects from severe acute lung failure.

Authors:  Yumiko Imai; Keiji Kuba; Shuan Rao; Yi Huan; Feng Guo; Bin Guan; Peng Yang; Renu Sarao; Teiji Wada; Howard Leong-Poi; Michael A Crackower; Akiyoshi Fukamizu; Chi-Chung Hui; Lutz Hein; Stefan Uhlig; Arthur S Slutsky; Chengyu Jiang; Josef M Penninger
Journal:  Nature       Date:  2005-07-07       Impact factor: 49.962

Review 7.  The renin-angiotensin system: going beyond the classical paradigms.

Authors:  Robson Augusto Souza Santos; Gavin Y Oudit; Thiago Verano-Braga; Giovanni Canta; Ulrike Muscha Steckelings; Michael Bader
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-02-01       Impact factor: 4.733

8.  Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension.

Authors:  Juan Meng; Guohui Xiao; Juanjuan Zhang; Xing He; Min Ou; Jing Bi; Rongqing Yang; Wencheng Di; Zhaoqin Wang; Zigang Li; Hong Gao; Lei Liu; Guoliang Zhang
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163
  8 in total
  3 in total

1.  Does admission acetylsalicylic acid uptake in hospitalized COVID-19 patients have a protective role? Data from the Spanish SEMI-COVID-19 Registry.

Authors:  Francesc Formiga; Manuel Rubio-Rivas; José María Mora-Luján; Samara Campos Escudero; Rosa Fernandez Madera Martinez; Manuel Mendez-Bailón; Pedro Durán-Del Campo; Andrea Riaño Pérez; Francisco-Javier García-Sánchez; José Nicolás Alcalá-Pedrajas; Sergio Arnedo Hernández; Almudena Hernández Milian; Ana Latorre Díez; Ricardo Gil Sánchez; Ramon Boixeda; Julio Vicente; Begoña Cortes; Carmen Mella Pérez; María Esther Guisado Espartero; José López Castro; Santiago Rodríguez Suárez; Jose F Varona; Ricardo Gomez-Huelgas; Jose Manuel Ramos-Rincón
Journal:  Intern Emerg Med       Date:  2021-11-29       Impact factor: 5.472

2.  Angiotensin enzyme inhibitors and angiotensin receptor blockers as protective factors in COVID-19 mortality: a retrospective cohort study.

Authors:  Ashkan Yahyavi; Nima Hemmati; Pegah Derakhshan; Behrooz Banivaheb; Arman Karimi Behnagh; Rozhin Tofighi; Alireza TehraniYazdi; Ali Kabir
Journal:  Intern Emerg Med       Date:  2020-10-21       Impact factor: 3.397

3.  "COVID-19: diagnosis, management and prognosis": a new topical collection of Internal and Emergency Medicine.

Authors:  Riccardo Polosa; Michele Spinicci; Domenico Prisco
Journal:  Intern Emerg Med       Date:  2020-07-30       Impact factor: 3.397
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.